Patent ID: 8460868
Filing Date: 2013-06-11
Classification: C12Q,G06Q

Abstract:
1. A method of detecting the presence of a polymorphism in the SV2C gene and administering a treatment to a human subject, the method comprising: obtaining a genomic sample from a human subject having or at risk of developing schizophrenia (SZ); detecting a CC at rs10474464, a CC at rs12152728, or a TT at rs10064352 in the genomic sample; identifying the subject having a CC at rs10474464, a CC at rs12152728, or a TT at rs10064352 in the genomic sample as likely to have an improved response to quetiapine as compared to control subject; and administering a treatment comprising quetiapine to the subject with a CC at rs10474464; CC at rs12152728, or TT at rs10064352.